Jana Lizrova Preiningerova
AuthID: R-00G-YGP
1
TITLE: The regulator's perspective: How should new therapies and follow-on products for MS be clinically evaluated in the future? Full Text
AUTHORS: Daan J A Crommelin; Karl Broich; Chris Holloway; Bianca Meesen; Jana Lizrova Preiningerova; Jean Louis Prugnaud; Beatriz Silva Lima;
PUBLISHED: 2016, SOURCE: MULTIPLE SCLEROSIS JOURNAL, VOLUME: 22, ISSUE: 2 Suppl
AUTHORS: Daan J A Crommelin; Karl Broich; Chris Holloway; Bianca Meesen; Jana Lizrova Preiningerova; Jean Louis Prugnaud; Beatriz Silva Lima;
PUBLISHED: 2016, SOURCE: MULTIPLE SCLEROSIS JOURNAL, VOLUME: 22, ISSUE: 2 Suppl
